1804: Isolation of Morphine from Opium (1804)

Friedrich Sertürner, a German pharmacist's apprentice, became the first scientist to isolate a pure
alkaloid from a plant source when he extracted morphine from raw opium resin between 1804 and 1806.
Opium had been used medicinally for thousands of years—ancient Sumerians cultivated the poppy as
far back as 3400 BCE—but its active constituents were entirely unknown.

Sertürner treated opium with ammonia and water to precipitate a white crystalline substance he
initially called "principium somniferum" and later "morphium," after Morpheus, the Greek god of
dreams. He demonstrated the compound's activity by administering it to dogs and, famously, to
himself and three young volunteers, documenting dose-dependent narcosis, nausea, and respiratory
depression. His 1817 paper in Annalen der Physik is widely regarded as the founding document of
alkaloid chemistry.

The isolation of morphine transformed pharmacology in two profound ways. First, it demonstrated
that a single chemical entity—not a complex mixture—could account for the pharmacological activity
of a botanical preparation. Second, it established the concept that pure compounds could be isolated,
characterised, standardised, and administered in reproducible doses. Morphine itself became the
template molecule for decades of structure–activity relationship studies, eventually yielding codeine,
heroin (1898), and ultimately the modern opioid analgesics.

Morphine's isolation also revealed the double-edged nature of powerful pharmacological agents: its
analgesic utility was matched by its addictive potential. The widespread use of morphine-containing
patent medicines through the 19th century—and injected morphine during the American Civil War—
contributed to the first recognised epidemic of opioid use disorder, foreshadowing regulatory
challenges that persist into the 21st century.